Reddit Posts
IBRX - I don't understand something
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT
🚨PENNY STOCKS & SMALL CAPS' CATALYSTS - Sept 12!
Dealing with Fears of Loss, that leads to many lost opportunities - help needed
Dealing with Fears of Loss, that leads to many lost opportunities - help needed
June's penny stock marvels: supercharge your portfolio with these gems!
Will $IBRX go to $7 or even $10 by may 23?
IBRX is ready for a squeeze, has just begun.
A List of Biotech Stocks With Major Price Movement and Continued Upside Potential.
$IBRX Strong after hours buying and chart grabbed my attention..$2 break could really send this..news of late points to some big things com.
Penny stocks in focus ($TRKA, $BTBT, $IBRX)
IBRX on the launch pad to double digit area
Top Doctors Discuss Blow Out Phase 3 results of Immunity Bio Quilt Study to treat bladder cancer
IBRX ImmunityBio has the vaccine for all covid variants and more
IBRX ImmunityBio has the cure for all covid variants
IBRX expecting BLA submission to FDA this month
$IBRX I am an idiot. I’m all in and I’m getting a biblical ass pounding. Every fucking stock I buy, it dies. #mayor of tard-city
$IBRX. I am an idiot. Tell me why I am being a tard and blowing away my paycheck on this pile of dogeshit.
$IBRX , $AMRS. Complete Joint Venture. NFA.
A Keytruda competitor has a BLA filing and the market is overlooking them!
Immunitybio is the next big thing or will they fade away due to the greed of the fat suits?
Apes 🦍 needed to End Covid - Buy IBRX - 1st 2nd Gen Vaccine
IBRX ImmunityBio announces primary endpoint met in bladder cancer trial
IBRX stock is one to get in on
https://www.streetinsider.com/Corporate+News/ImmunityBio+%28IBRX%29+Announces+Positive+Durable+Responses+in+BCG+Unresponsive+Bladder+Cancer+Patients+with+a+Complete+Response+Rate+of+72%25%2C+Median+Duration+of+Complete+Response+of+19.9+Months%2C+and+85%25+R/18931016.html
ImmunityBio (IBRX) Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% R
$IBRX their bladder cancer treatment is nearly 2x more effective than the leading treatment.
IBRX, Immunitybio, 72% Complete Response for bladder cancer
IBRX, Immunitybio, 72% Complete Response for bladder cancer
IBRX, Immunitybio, 72% Complete Response for bladder cancer
Mentions
Tried IBRX and TCON last year. Made -40%. Never again
Just a heads up on this - $IBRX crosses above the 50-day SMA tomorrow, for the first time since December 10th. https://preview.redd.it/yeilqe1897ge1.jpeg?width=213&format=pjpg&auto=webp&s=d0a25d4c7903ed1bcfaf80a6f33f4f7e16b53254
Not at all as exciting as SPGC or MGOL... but if you're holding any IBRX that's starting a nice little climb
IBRX... volume is up. Anyone else think this is a play again?
IBRX is starting to take off. They’re on phase 3 trials.
Yeet it into mid summer calls on SMCI LUNR RKLB SOFI KODK SOUN IBRX One of those might hit big.
# **TLDR** --- **Ticker:** IBRX **Direction:** Up **Prognosis:** Strong Buy **Reasoning:** High insider ownership (93.88%), huge short interest (111.44%), and analyst price targets significantly above current price suggest potential for a substantial price increase. Chart shows a possible breakout from a descending triangle pattern. **Caveat:** Negative ROA (-147.50%) is a significant red flag and needs further investigation. High risk investment.
Currently holding: CTM, IBRX, HAO, MDAI, WKSP. What am I missing, for swing trades?[](https://www.reddit.com/user//)
$IBRX looks posed for a nice bounce. Might be worth looking into
IBRX starting to make a bit of recovery. Hoping it stays over 3 now
Damn. If IBRX establishes a foothold in the market it could be a crazy squeeze
88% of $IBRX is held by institutions.
36% percent Do dd and check All in IBRX 🚀🚀
$IBRX 🚀🚀 https://www.stocktitan.net/news/IBRX/first-patients-dosed-in-phase-1-clinical-study-of-immunity-bio-s-car-sgd2uwncnlle.html
$IBRX 🚀🚀🚀 https://www.stocktitan.net/news/IBRX/first-patients-dosed-in-phase-1-clinical-study-of-immunity-bio-s-car-sgd2uwncnlle.html
$IBRX- 38% short squeeze Public offering for stocks $30 target 🚀🚀
IBRX fuked me good today after they announce dilution, no movement on MCD in the last 2 months, CLSK and LUNR keep shitting on me … just to name a few
No, IBRX is curing cancer and they're down 30% today lmao
$IBRX 
Good thing I held onto IBRX instead of cashing out when it was over $5 
I sold a long ass time ago but I just saw they did a dilution and I know there's still a couple IBRX gards up in here
ALL YOU IBRX REGARDS THAT RECCOMENDED EXPLAIN YOURSELVES WHAT THE FUCK HAPPENED????  WHERES THE PROFITS FOR THE CANCER DRUG???
$IBRX JUST GOING TO XPLODE 🚀🚀🚀🚀 https://www.stocktitan.net/news/IBRX/immunity-bio-inc-announces-pricing-of-public-offering-of-common-hkgplpzusv3w.html
https://www.stocktitan.net/news/IBRX/immunity-bio-inc-announces-pricing-of-public-offering-of-common-hkgplpzusv3w.html
$IBRX is the next KULR READY GUYS 🚀🚀🚀
It seems that IBRX stock price started to fall yesterday
That isn't how you spell IBRX
Those biotechs scare me... IBRX got me and now I'm scared for life 
Exactly. IBRX was all the rage earlier this year, and there’s been a handful of others since then. Some have done well - but lots of pump and dump in the bio sector.
Anyone else have IBRX calls that spike up at exactly 12:50pm (PST) and then shoot back down? Been going on for about 2 weeks now.
IBRX $10 when? Can’t you see they’re curing cancer!
In IBRX for a few weeks now, this should be a good hold. Europe Anktiva next!
Thanks for the DD and I’ll have a closer look this weekend. The price action doesn’t scare me. This reminds me of IBRX as it was just projected to do 800% by EF Hutton, had it’s first earnings beat in company history and has since dropped 20% over the past week as well. GL on your play.
Not sure how i’m down 100% on my IBRX 12/25 $7.50 calls but ok.
IBRX earnings was very solid, but it's dropping, very strange, this company has amazing future!
Anyone here ever heard of IBRX? I just want to pump it here :) Thank you for your time.
Ssssoooo IBRX beat expectations by 13% but no movement?
I hope IBRX actually reports today, with an actual news release, this fucker
Here's LUNR: Intuitive Machines, Inc. (LUNR) is currently trading at $7.77, with mixed sentiment but a slight positive tilt due to anticipation of upcoming earnings and a significant NASA contract. The stock has shown recent volatility, with technical indicators like the RSI around 50 suggesting moderate buying pressure, while the MACD histogram indicates potential bearish momentum. The broader market's cautious optimism, driven by tech sector strength and anticipated rate cuts, may provide some support, though LUNR's movement could be independent due to its unique catalysts. Given the high borrowing fees and potential for short covering, a speculative long position could be considered. An entry at $7.70, with a first target of $8.00 and a second target of $8.20, seems reasonable, setting a stop loss at $7.50 to manage downside risk. Confidence in reaching the first target is moderate at 60%, given the mixed sentiment and technical setup, while the second target carries lower confidence at 40% due to potential volatility and lack of additional catalysts. Investors should remain vigilant of any news developments and broader market shifts that could impact LUNR's trajectory. And here's IBRX: ImmunityBio, Inc. (IBRX) is currently trading at $5.43, with a mixed but optimistic sentiment driven by EF Hutton's $30 price target and promising drug pipeline, despite financial concerns and high short interest. The stock has shown recent upward momentum, supported by technical indicators like the 10-day SMA at $5.15 and a bullish MACD histogram. The RSI around 65 suggests it's nearing overbought territory, indicating potential for a pullback. Broader market optimism, particularly in tech, could provide additional support, though caution is warranted due to potential volatility from geopolitical and economic factors. For today's session, consider a long position with an entry at $5.40, targeting $5.60 and $5.80, with a stop loss at $5.20. Confidence in the first target is moderate due to current momentum, while the second target carries lower confidence given external risks. Overall, the cautious optimism surrounding IBRX aligns with broader market trends, but investors should remain vigilant of potential headwinds. Unfortunately we only target US stocks right now so we can't do HE1, sorry!
But when is IBRX hitting $8?
Regards, thoughts on IBRX and LAC earnings?
IBRX SOFI. Maybe not the users but the investors love getting wrecked by these guys. Finally some upwards trends but we’ll hold through the downward plunge.
How is my IBRX $6 exp 11/1 cash secured put still -36%?
IBRX reports first full quarter earnings in a few days. IMO should rise
As a IBRX holder, I can tell you, curing cancer isn’t even enough.
IBRX puts printing all day long. Thank you.
IBRX being artificially kept at $5.60. Make it anymore obvious no? Lmao
Certainly! IBRX: ImmunityBio, Inc. (IBRX) is showing strong bullish momentum, with the current price at $5.58 significantly above its 10-day SMA of $4.25 and a high RSI indicating overbought conditions. The MACD histogram is positive, suggesting continued upward momentum, while recent volume spikes indicate heightened interest. Despite the lack of specific news, the broader market's cautious optimism and IBRX's technical indicators suggest potential for further gains. Given the current setup, consider entering a long position around $5.60, targeting $6.00 as the first price target and $6.30 as the second, with a stop loss at $5.30 to manage downside risk. Confidence in reaching the first target is high due to strong technical indicators, while the second target carries moderate confidence given potential resistance near recent highs. Keep an eye on broader market sentiment and any emerging news that could impact biotech stocks. VKTX: Viking Therapeutics, Inc. (VKTX) is poised for potential upside today, driven by strong momentum from its promising weight loss drug candidate, VK2735, and robust Q3 earnings. The stock has surged over 21% recently, supported by a solid cash position and positive market sentiment towards biotech innovations. Technical indicators show a bullish trend with the current price of $73.35 above key moving averages (10-day SMA at $68.21 and 8-day EMA at $70.53), and a MACD histogram indicating upward momentum. RSI levels are moderately high, suggesting continued buying interest but cautioning against overbought conditions. Given the broader market's cautious optimism, VKTX could benefit from sector strength in healthcare. For today's session, consider entering around $73.00, targeting $75.50 initially and $78.00 as a secondary target, with a stop loss at $71.00 to manage downside risk. Confidence in reaching the first target is high due to recent positive news and technical alignment, while the second target carries moderate confidence given potential market volatility. RDFN: Redfin Corporation (RDFN) is currently trading at $9.71, showing a bearish trend with significant downward momentum as indicated by the MACD and RSI values, both of which suggest oversold conditions. The stock has been under pressure, with recent candles reflecting a consistent decline from highs around $12.50, aligning with broader market caution despite SPY's resilience. The 10-day SMA at $10.38 and 20-day EMA at $10.63 highlight a bearish crossover, reinforcing the downtrend. Recent news categorizing RDFN as a risky asset further dampens sentiment, potentially increasing selling pressure. For today's session, consider shorting RDFN with an entry around $9.70, targeting $9.50 initially and $9.30 subsequently, while setting a stop loss at $10. Confidence in reaching the first target is high due to prevailing bearish indicators, while the second target holds moderate confidence given potential volatility. Stay vigilant for any unexpected market shifts that could impact this setup. SOUN: SoundHound AI, Inc. (SOUN) is currently trading at $6.02, showing strong momentum driven by the broader surge in AI stocks and positive sentiment around its voice recognition technology. The stock has been on an upward trajectory, with the 10-day SMA at $5.42 and the 8-day EMA at $5.53, indicating bullish momentum. The RSI levels are above 70, suggesting overbought conditions, but the MACD histogram remains positive, supporting further upside potential. Given the recent high volume spikes and the favorable market sentiment towards AI, a long position could be considered. Enter at $6.00, targeting $6.20 as the first price target and $6.35 as the second, with a stop loss at $5.80 to manage downside risk. Confidence in reaching the first target is high due to strong technical indicators, while the second target carries moderate confidence given potential resistance and broader market volatility. Keep an eye on any shifts in market sentiment or news that could impact AI stocks. MSFT: Microsoft (MSFT) is currently trading at $437.08, showing strong momentum with a 6-day RSI of 75.15, indicating overbought conditions but also potential for continued upward movement. The MACD histogram is positive, suggesting bullish momentum, while the stock has been consistently closing above its 8-day EMA of $425.75, reinforcing a short-term uptrend. Recent news highlights Microsoft's strategic positioning in AI and cloud computing, which could drive further gains despite low growth expectations in Azure. The broader market sentiment, with SPY and QQQ showing resilience, supports a cautiously optimistic outlook for tech stocks. For today's session, consider entering a long position around $435.00, targeting $440.00 as the first price target and $445.00 as the second, with a stop loss at $430.00 to manage downside risk. Confidence in reaching the first target is high due to strong technical indicators, while the second target carries moderate confidence given potential resistance near $450.00. Stay vigilant for any shifts in market sentiment or unexpected news that could impact the stock's trajectory. CORZ: Core Scientific, Inc. (CORZ) is showing strong bullish momentum, with the current price at $14.37, well above its 10-day SMA of $13.47 and 20-day EMA of $13.05, indicating a positive trend continuation. The RSI values are in the overbought territory, suggesting potential for a pullback, but the MACD histogram remains positive, supporting further upward movement. Recent volume spikes, notably surpassing the 65-day average, highlight increased buying interest. Given the broader market's cautious optimism and tech sector strength, CORZ could benefit from sector tailwinds. For today's session, consider entering around $14.30, targeting $14.70 initially and $15.00 as a secondary target, with a stop loss at $14.00 to manage downside risk. Confidence in reaching the first target is high due to technical indicators, while the second target carries moderate confidence given potential resistance and market volatility.
How about: IBRX, VKTX, RDFN, SOUN, MSFT, CORZ Thanks!
IBRX isn't coming back, is it?
You were right about IBRX so I'm behind you 100% 🚀🌕 Except for CHRS lol 😆
Where did the IBRX pumpers go? I didn't finish making my order.
I just need IBRX to run one more day, please.
IBRX is at 6 dollars right now, back in may it managed to hit 9. There's still a ceiling it hasn't touched yet!
Buy $IBRX short squeeze to $40
Im finally even on IBRX. I averaged down so many times. Everyone knows Biotech is risk free please join me🗣️🗣️
DTJ and IBRX. Same as every day these last two weeks
IBRX is still pumping. Heavily shorted and recent price target of $30. Already up 80+% on shares. Diamond handing.
IBRX…this could be interesting in an exponential way. Monitoring
IBRX is at 200% volume already.
IBRX popping off with bigly volume
$IBRX is really on the road to +600% my gawd.
Let's go $IBRX. Price target of $30 giving early ASTS vibes.
Second day of pump for IBRX
IBRX has fuel in the tank still!
Anyone think IBRX is going to run again?
Guesses? NN SOUN SOFI IINN IBRX I like the companies but, they’re just guesses and I’m willing to wait out the time and see.
LUMN IBRX Wild guesses. But there's definitely a small bio tech company out there that will hit it big. Perhaps one with breakthroughs in oncology, or alzheimers, or vaccines. Who knows. Will definitely be tech companies too. Hard to say what tiny company will soar though Also bullish on others mentioned here. Wish I held on to rddt and ionq! Waiting for a good entry
IBRX dipped back down to $5.30 within a few hours of this post. If your break even price is over $7, doesn’t that mean you’re back in the red?
dayum IBRX had a violent rise to $7.50 and then an equally violent pullback. The worst part is my 10x 7c expired worthless last week :((( Still riding leaps tho
dayum IBRX had a violent rise to $7.50 and then an equally violent pullback. The worst part is my 10x 7c expired worthless last week :((( Still riding leaps tho
I think it's possible IBRX maintains a higher floor, but because of the good news we're on day 2 of investors piling in. Expect a pull back, invest when you feel comfortable, and hold.
Someone mentioned IBRX & I bought it AF on 10/23, up 90% & climbing on em!
Whoever mentioned IBRX on or around 10/23, I thank you SO MUCH! I think I'm about to be +100% on em soon! I bought em AH on 10/23...